Zenwick Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.20 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
- Revenue Growth 44.86%
- Profit Growth 95.63%
- Ebitda -83.52%
- Net Worth 28.52%
- Total Assets 141.70%
About Zenwick Pharma
Zenwick Pharma Private Limited (ZPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 April 2017 (Seven years and ten months 14 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹4.00 M.
Radhakrishnan, Nandanan Krishnankutty, Sowmya Rajan, and Two other members serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909KL2017PTC048858
- Company No.
048858
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Zenwick Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suraj Sureshbabu  | Managing Director | 27-Jan-2022 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Radhakrishnan | Director | 07-Jun-2024 | Current |
| Nandanan Krishnankutty | Director | 12-Apr-2017 | Current |
| Sowmya Rajan | Additional Director | 27-Mar-2024 | Current |
| Manamel Sajinkumar | Director | Current |
Financial Performance of Zenwick Pharma.
Zenwick Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.86% increase. The company also saw a substantial improvement in profitability, with a 95.63% increase in profit. The company's net worth Soared by an impressive increase of 28.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenwick Pharma?
Unlock access to Zenwick Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Zenwick Pharma Life Private LimitedManamel Sajinkumar is a mutual person
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Mar 2022 | Hdfc Bank Limited | ₹4.00 M | Open |
How Many Employees Work at Zenwick Pharma?
Unlock and access historical data on people associated with Zenwick Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenwick Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenwick Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
